E. Hyman Steven's most recent trade in Voyager Therapeutics Inc was a trade of 24,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Voyager Therapeutics Inc | Steven E. Hyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
Cyclerion Therapeutics Inc | E. Hyman Steven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
Voyager Therapeutics Inc | Steven E. Hyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
Cyclerion Therapeutics Inc | Steven E. Hyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 57,753 | 57,753 | - | - | Stock Option (Right to Buy) | |
Voyager Therapeutics Inc | Steven E. Hyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) |